# Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml

> **NCT03735771** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 20 (actual)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03735771
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-03
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03735771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03735771, "Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03735771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*